Clinical Trial Update: Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (HI-MOC) evaluating secondary cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy for recurrent mucinous ovaria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucinous Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING